A Novel Co-Occurrence between Cerebral Sinovenous Thrombosis and Non-ketotic Hyperglycinemia in a Neonate-a Case Report

Document Type : Case Report

Authors

1 Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Radiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

10.22038/ijn.2024.78536.2526

Abstract

Background: Cerebral venous sinus thrombosis (CSVT) is a relatively rare condition characterized by seizures, cerebral edema, lethargy, and encephalopathy. In neonates, lethargy often indicates central nervous system (CNS) dysfunction, necessitating a comprehensive evaluation for various potential diagnoses including cerebrovascular accidents, infections, and metabolic disorders. Non-ketotic hyperglycinemia (NKH) is an autosomal recessive disorder, also known as glycine encephalopathy, resulting from a deficiency in the enzyme responsible for glycine catabolism. This leads to elevated levels of glycine in the blood, urine, and cerebrospinal fluid (CSF), accompanied by severe seizures, hypotension, hiccups, apnea, and progressive lethargy, which may progress to encephalopathy or even death.
Case Report: This report presents the case of a 3-day-old neonate admitted to the hospital with opioid toxicity, displaying reduced metabolic activity. Despite initial suspicion of ketotic hyperglycemia, further investigation revealed the presence of cerebral sinus thrombosis in addition to NKH.
Conclusion: This case underscores the complexity of neonatal presentations and highlights the importance of considering multiple differential diagnoses, especially when faced with unusual or overlapping clinical features. Early recognition and appropriate management of CSVT and NKH are crucial in improving outcomes for affected neonates.
 

Keywords

References

  1. Eilers L, Harrington JW. Neonatal lethargy, seizures, and asphyxiation. Pediatr Rev. 2017;38(6):290-291.
  2. Hoover-Fong JE, Shah S, Van Hove JL, Applegarth D, Toone J, Hamosh A. Natural history of nonketotic hyperglycinemia in 65 patients. Neurology. 2004;63(10):1847-1853.
  3. Ramenghi LA, Cardiello V, Rossi A. Neonatal cerebral sinovenous thrombosis. Handb Clin Neurol. 2019;162:267-280.
  4. Nafissi N, Heiranizadeh N, Shirinzadeh-Dastgiri A, Vakili-Ojarood M, Naseri A, Danaei M, et al. The Application of Artificial Intelligence in Breast Cancer. EJMO. 2024;8(3):235–244.
  5. Berfelo FJ, Kersbergen KJ, van Ommen CH, Govaert P, van Straaten HL, et al. Neonatal cerebral sinovenous thrombosis from symptom to outcome. Stroke. 2010;41(7):1382-1388.
  6. Yang JY, Chan AK, Callen DJ, Paes BA. Neonatal cerebral sinovenous thrombosis: sifting the evidence for a diagnostic plan and treatment strategy. Pediatrics. 2010;126(3):e693-700.
  7. Dlamini N, Billinghurst L, Kirkham FJ. Cerebral venous sinus (sinovenous) thrombosis in children. Neurosurg Clin N Am. 2010;21(3):511-527.
  8. Ichord R. Cerebral sinovenous thrombosis. Front Pediatr. 2017;5:163.
  9. Yurttutan S, Oncel MY, Yurttutan N, Degirmencioglu H, Uras N, Dilmen U. A novel association between cerebral sinovenous thrombosis and nonketotic hyperglycinemia in a neonate. Korean J Pediatr. 2015;58(6):230-233.
  10. Nowak M, Chuchra P, Paprocka J. Nonketotic hyperglycinemia: Insight into current therapies. J Clin Med. 2022;11(11):3027.
  11. Rasmuson T, Kristoffersson A, Boquist L. Positive effect of radiotherapy and surgery on hormonally active pulmonary metastases of primary parathyroid carcinoma. Eur J Endocrinol. 2000;143(6):749-754.
  12. Tada K. Nonketotic hyperglycinemia: clinical and metabolic aspects. Enzyme. 1987;38(1-4):27-35.
  13. Wei SH, Weng WC, Lee NC, Hwu WL, Lee WT. Unusual spinal cord lesions in late-onset non-ketotic hyperglycine J Child Neurol. 2011;26(7):900-903.

 

Iranian Journal of Neonatology
Volume 15, Issue 4
October 2024
Pages 54-58

Files

Share

How to cite

Statistics